BSEDipna Pharmachem LtdHighNeutral
Announced Thu, 2 Jul · 21:18 IST

FY26 PAT surges 170% to Rs 263 lakh led by steel segment

Pat Growth 25pctNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹6.00
prior close
₹6.06
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.1+0.0-4.5-6.3+5.0-3.2-7.2-16.0
Up moveDown movePending
AI summary

Board approved audited FY26 results on 2 July 2026. Revenue from operations rose about 3% YoY to Rs 12,908 lakh (vs Rs 12,492 lakh). PAT jumped 170% to Rs 263 lakh (vs Rs 97 lakh), with EPS at Rs 1.00 (vs Rs 0.41). Steel segment turned in Rs 867 lakh profit versus Rs 18 lakh last year, while chemicals segment swung to a Rs 512 lakh loss from a Rs 124 lakh profit. Auditor Devadiya and Associates gave an unmodified opinion. Operating cash flow stayed negative at minus Rs 1,832 lakh versus minus Rs 919 lakh. No deviation reported in use of preferential warrant issue proceeds.

Likely market impact

Strong headline PAT growth driven by steel, but chemicals turned loss-making and operating cash flow remains deeply negative — mixed picture for shareholders.